VOLtage-based Contrast Media AdaptatioN in Coronary Computed Tomography Angiography

NCT03179592 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2020-02-13

No results posted yet for this study

Summary

The purpose of this study is to prospectively evaluate the effectiveness of low-volume contrast media (CM) injection protocols adapted to tube voltage in patients undergoing Coronary Computed Tomography Angiography (CCTA).

Conditions

Interventions

DRUG

Ultravist 370Mg I/Ml Solution for Injection

Reduced contrast-volume injection protocols based on patient specific tube voltage.

Sponsors & Collaborators

  • Bayer

    collaborator INDUSTRY
  • Medical University of South Carolina

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-22
Primary Completion
2019-02-11
Completion
2019-02-11
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03179592 on ClinicalTrials.gov